Evidence map›Paper›PMID 40453059›Full record

ArticleBlood neoplasia2024

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

Amy E DeZern, Johannes B Goll, Travis L Jensen, Sridhar Nonavinkere Srivatsan, Nancy K Gillis, Gregory A Abel, Eric Padron, H Joachim Deeg, Tareq Al Baghdadi, Jane Jijun Liu and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Amy E DeZernJohns Hopkins University, Baltimore, MD.
Johannes B GollThe Emmes Company, Rockville, MD.
Travis L JensenThe Emmes Company, Rockville, MD.
Sridhar Nonavinkere SrivatsanDepartment of Medicine, Division of Oncology Washington University School of Medicine, Washington University, St. Louis, MO.
Nancy K GillisH. Lee Moffitt Cancer Center, Tampa, FL.
Gregory A AbelDana-Farber Cancer Institute, Boston, MA.
Eric PadronH. Lee Moffitt Cancer Center, Tampa, FL.
H Joachim DeegFred Hutchinson Cancer Research Center, Seattle, WA.
Tareq Al BaghdadiIHA Hematology Oncology Consultants, Ypsilanti, MI.
Jane Jijun LiuIllinois CancerCare, Peoria, IL.
Rami S KomrokjiH. Lee Moffitt Cancer Center, Tampa, FL.
Steven D GoreDivision of Cancer Prevention, National Cancer Institute, Rockville, MD.
Wael SaberMedical College of Wisconsin, Milwaukee, WI.
Rafael BejarDivision of Hematology/Oncology, University of California, San Diego, La Jolla, CA.
Matthew J WalterDepartment of Medicine, Division of Oncology Washington University School of Medicine, Washington University, St. Louis, MO.
R Coleman LindsleyDana-Farber Cancer Institute, Boston, MA.
Seth ShermanThe Emmes Company, Rockville, MD.
Nancy DiFronzoDivision of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, Bethesda, MD.
Mikkael A SekeresSylvester Comprehensive Cancer Center, University of Miami, Miami, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40453059
PMCPMC12082164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.